Pharma Journalist - Page 111 of 957 -

Cognizant Extends Gilead Partnership to Expand AI-Enabled DevOps

CSL, Alentis Partner on $1.55B Kidney and Liver Drug

Alector Licenses Parkinson’s Drug Program to Genentech for $1.27B

Rilzabrutinib Receives Orphan Drug Designation for Two Rare Diseases

Novartis Gets FDA Accelerated Approval for Vanrafia in IgAN

Flagship Pioneering and Pfizer Partner to Develop Selective Inhibitors for Autoimmune Diseases

Astellas Partners with Japanese Cancer Foundation to Boost Oncology Research

EU Approves Pfizer’s RSV Vaccine ABRYSVO for Adults 18-59

Apellis Gets FDA Priority Review for EMPAVELI in C3G, IC-MPGN

AIRNA Secures $155M in Oversubscribed Series B for Alpha-1 Antitrypsin Trial

Amneal Launches BORUZU, First Ready-to-Use Bortezomib Injection

Bavarian Nordic Gets FDA Approval for Smallpox, Mpox Vaccine

Qfitlia Approved as First US Therapy for Hemophilia A/B with or without Inhibitors